Daniel B. McClatchy
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Daniel B. McClatchy has a total of 177 co-authors. Here are the top co-authors by number of shared publications:
- John Robert Yates
Department of Molecular Medicine, The Scripps Research Institute, La Jolla, CA 92037, USA
28 shared publications - Salvador Martínez-Bartolomé
Department of Integrative Structural & Computational Biology, The Scripps Research Institute, 10550 North Torrey Pines Road, La Jolla, CA, 92037, USA
8 shared publications - Jolene K. Diedrich
Department of Molecular Medicine, Scripps Research Institute, La Jolla, CA 92037, USA
4 shared publications - Nam-Kyung Yu
Department of Biological Sciences, College of Natural Sciences, Seoul National University, Seoul 08826, South Korea
4 shared publications - Yuanhui Ma
The Scripps Research Institute
4 shared publications - Alysson Renato Muotri
Department of Pediatrics, University of California San Diego, San Diego, USA
3 shared publications
Latest Publications
- Open Access
Quantitation of Spatial Proteoforms in Alzheimer's Disease
Alzheimer's disease (AD) pathogenesis involves complex, multifactorial changes to the brain proteome that conventional unfractionated analyses may obscure. Proteins frequently occupy multiple subcellular compartments as spatial proteoforms, yet the contribution of aberrant protein localization to AD pathogenesis remains poorly understood. To address this, we fractionated post-mortem human hippocampi from 13 AD and 14 non-AD individuals into four subcellular fractions and quantified 6,123 proteins by TMT-LC-MS. Although 75% of proteins were detected in more than one fraction, 78% of significant AD-associated alterations were restricted to a single fraction, demonstrating that subcellular localization is a primary determinant of disease vulnerability. Discordant abundance patterns between fractions revealed retromer complex mislocalization, nuclear transport dysfunction, and insoluble protein accumulation, with the endosomal-lysosomal and protein folding pathways most consistently perturbed. To examine how these perturbations evolve with disease progression, we applied the QUAD strategy to measure protein degradation in two fractions of APPswePS1delta9 mouse cortex at 2, 5, and 12 months. Degradation rates diverged between fractions and genotypes in an age-dependent manner, and cross-dataset comparison identified six proteins altered at the earliest pre-pathological timepoint, implicating vesicle transport and proteostasis disruption as initiating features of AD. These findings establish spatial proteoforms as essential units of pathogenic analysis and reveal disease-relevant signals invisible to bulk tissue approaches.
Open AccessQuantitation of Spatial Proteoforms in Alzheimer's Disease
Alzheimer's disease (AD) pathogenesis involves complex, multifactorial changes to the brain proteome that conventional unfractionated analyses may obscure. Proteins frequently occupy multiple subcellular compartments as spatial proteoforms, yet the contribution of aberrant protein localization to AD pathogenesis remains poorly understood. To address this, we fractionated post-mortem human hippocampi from 13 AD and 14 non-AD individuals into four subcellular fractions and quantified 6,123 proteins by TMT-LC-MS. Although 75% of proteins were detected in more than one fraction, 78% of significant AD-associated alterations were restricted to a single fraction, demonstrating that subcellular localization is a primary determinant of disease vulnerability. Discordant abundance patterns between fractions revealed retromer complex mislocalization, nuclear transport dysfunction, and insoluble protein accumulation, with the endosomal-lysosomal and protein folding pathways most consistently perturbed. To examine how these perturbations evolve with disease progression, we applied the QUAD strategy to measure protein degradation in two fractions of APPswePS1delta9 mouse cortex at 2, 5, and 12 months. Degradation rates diverged between fractions and genotypes in an age-dependent manner, and cross-dataset comparison identified six proteins altered at the earliest pre-pathological timepoint, implicating vesicle transport and proteostasis disruption as initiating features of AD. These findings establish spatial proteoforms as essential units of pathogenic analysis and reveal disease-relevant signals invisible to bulk tissue approaches.
- Open Access
ESCRT-0 regulates AMPA receptor currents and Ca 2+ - dependent signaling
Membrane protein trafficking is essential for synaptic growth, maintenance, function, and plasticity, and involves the regulated exocytosis and endocytosis of proteins to and from the pre-and post-synaptic membranes. Defects in the clearance of membrane proteins can lead to the accumulation of ubiquitinated membrane proteins and contribute to neurodegenerative disease. The ESCRT (endosomal sorting complexes required for transport) machinery binds and sorts ubiquitinated membrane proteins into lysosomes for degradation, yet the presence and function of ESCRTs in sorting ubiquitinated AMPA and other receptors at the post-synapse remain unclear. Here we show that the ubiquitin-binding ESCRT-0 protein, Hrs, localizes to both pre- and post-synapses, and levels are modulated by neuronal activity, increasing and decreasing with higher and lower neuronal activity, respectively. Phosphoproteomic profiling of Hrs-depleted post-synaptic membranes revealed a role for Hrs in glutamatergic synaptic transmission, including long-term potentiation. In addition, Hrs-depleted neurons showed faster AMPAR current kinetics and reduced amplitude in whole-cell patch-clamp recordings. Genetic deletion of neuronal Hgs in mice led to reductions in phosphorylated CaMKII-α and -β (T286/T287) and structural proteins, PSD-95 and gephyrin, suggestive of LTD (long-term depression)-like synaptic depression. In contrast, Hrs overexpression led to increases in Ca 2+ -dependent signaling, including protein kinase C (PKC) and PKC substrate, AMPAR subunit GluA1-S831, a site which increases conductance. Together, these findings identify a dynamic, bidirectional role for Hrs at the post-synapse as it both senses and is modulated by neuronal activity, ultimately impacting excitatory synaptic strength. Significance Statement: Synaptic plasticity relies on dynamic trafficking and turnover of membrane proteins, including AMPA-type glutamate receptors (AMPARs), yet how receptor trafficking intersects with ubiquitin-mediated sorting pathways at synapses remains unclear. We show that the ubiquitin-binding ESCRT-0 protein, Hrs, localizes to both pre- and post-synapses, and its abundance is bidirectionally regulated by neuronal activity. Genetic depletion of Hrs in mice reduces CaMKII phosphorylation and impacts AMPAR channel surface localization. In contrast, neuronal-specific Hrs overexpression led to enhanced GluA1 and protein kinase C substrate phosphorylation, suggesting altered AMPAR trafficking, subunit composition, and/or function. Thus, Hrs emerges as a modulator of glutamatergic signaling, coupling ubiquitin-mediated receptor sorting to the fine-tuning of synaptic transmission, with direct implications for learning and memory in health and disease.
Open AccessESCRT-0 regulates AMPA receptor currents and Ca 2+ - dependent signaling
Membrane protein trafficking is essential for synaptic growth, maintenance, function, and plasticity, and involves the regulated exocytosis and endocytosis of proteins to and from the pre-and post-synaptic membranes. Defects in the clearance of membrane proteins can lead to the accumulation of ubiquitinated membrane proteins and contribute to neurodegenerative disease. The ESCRT (endosomal sorting complexes required for transport) machinery binds and sorts ubiquitinated membrane proteins into lysosomes for degradation, yet the presence and function of ESCRTs in sorting ubiquitinated AMPA and other receptors at the post-synapse remain unclear. Here we show that the ubiquitin-binding ESCRT-0 protein, Hrs, localizes to both pre- and post-synapses, and levels are modulated by neuronal activity, increasing and decreasing with higher and lower neuronal activity, respectively. Phosphoproteomic profiling of Hrs-depleted post-synaptic membranes revealed a role for Hrs in glutamatergic synaptic transmission, including long-term potentiation. In addition, Hrs-depleted neurons showed faster AMPAR current kinetics and reduced amplitude in whole-cell patch-clamp recordings. Genetic deletion of neuronal Hgs in mice led to reductions in phosphorylated CaMKII-α and -β (T286/T287) and structural proteins, PSD-95 and gephyrin, suggestive of LTD (long-term depression)-like synaptic depression. In contrast, Hrs overexpression led to increases in Ca 2+ -dependent signaling, including protein kinase C (PKC) and PKC substrate, AMPAR subunit GluA1-S831, a site which increases conductance. Together, these findings identify a dynamic, bidirectional role for Hrs at the post-synapse as it both senses and is modulated by neuronal activity, ultimately impacting excitatory synaptic strength. Significance Statement: Synaptic plasticity relies on dynamic trafficking and turnover of membrane proteins, including AMPA-type glutamate receptors (AMPARs), yet how receptor trafficking intersects with ubiquitin-mediated sorting pathways at synapses remains unclear. We show that the ubiquitin-binding ESCRT-0 protein, Hrs, localizes to both pre- and post-synapses, and its abundance is bidirectionally regulated by neuronal activity. Genetic depletion of Hrs in mice reduces CaMKII phosphorylation and impacts AMPAR channel surface localization. In contrast, neuronal-specific Hrs overexpression led to enhanced GluA1 and protein kinase C substrate phosphorylation, suggesting altered AMPAR trafficking, subunit composition, and/or function. Thus, Hrs emerges as a modulator of glutamatergic signaling, coupling ubiquitin-mediated receptor sorting to the fine-tuning of synaptic transmission, with direct implications for learning and memory in health and disease.
- Open Access
- 7 March 2026
- Published by Springer Nature in Schizophrenia
- Vol. 12 (1)
In vivo mapping of protein-protein interactions of schizophrenia risk factors generates an interconnected disease network
Genetic analyses of schizophrenia (SCZ) patients have identified thousands of risk factors. In silico protein-protein interaction (PPI) network analysis has provided strong evidence that disrupted PPI networks underlie SCZ pathogenesis. In this study, we performed in vivo PPI analysis of several SCZ risk factors (i.e., Grin2b, Grm5, Gsk3b, Map2k1, Ppp1ca, Stx1a, Syngap1, and Syt1) in the rodent brain. Using endogenous antibody immunoprecipitations analyzed by liquid chromatography coupled to mass spectrometry, we constructed a SCZ network comprising 1612 unique PPI with a 5% FDR. Over 90% of the PPIs have not been previously reported. AlphaFold3 was employed to identify direct PPI interactors. Our SCZ PPI network was enriched with known SCZ risk factors, which supports the hypothesis that an accumulation of disturbances in selected PPI networks underlies SCZ. We used Stable Isotope Labeling in Mammals (SILAM) to quantitate phencyclidine (PCP) perturbations in the SCZ network and found that PCP weakened most PPI but also led to some enhanced or new PPI. These findings demonstrate that quantifying PPI in perturbed biological states can reveal alterations to network biology.
- 7 March 2026
- Published by Springer Nature in Schizophrenia
- Vol. 12 (1)
Open AccessIn vivo mapping of protein-protein interactions of schizophrenia risk factors generates an interconnected disease network
Genetic analyses of schizophrenia (SCZ) patients have identified thousands of risk factors. In silico protein-protein interaction (PPI) network analysis has provided strong evidence that disrupted PPI networks underlie SCZ pathogenesis. In this study, we performed in vivo PPI analysis of several SCZ risk factors (i.e., Grin2b, Grm5, Gsk3b, Map2k1, Ppp1ca, Stx1a, Syngap1, and Syt1) in the rodent brain. Using endogenous antibody immunoprecipitations analyzed by liquid chromatography coupled to mass spectrometry, we constructed a SCZ network comprising 1612 unique PPI with a 5% FDR. Over 90% of the PPIs have not been previously reported. AlphaFold3 was employed to identify direct PPI interactors. Our SCZ PPI network was enriched with known SCZ risk factors, which supports the hypothesis that an accumulation of disturbances in selected PPI networks underlies SCZ. We used Stable Isotope Labeling in Mammals (SILAM) to quantitate phencyclidine (PCP) perturbations in the SCZ network and found that PCP weakened most PPI but also led to some enhanced or new PPI. These findings demonstrate that quantifying PPI in perturbed biological states can reveal alterations to network biology.
- Open Access
- 23 December 2025
- Published by Wiley in Alzheimer's & Dementia
- Vol. 21 (S1) , e103003
Alzheimer's Disease Pathogenesis Perturbs Specific Spatial Protein Isoforms
Background: Unbiased mass spectrometry (MS) analyses have quantitated hundreds of Alzheimer's Disease (AD) human brain samples to reveal potential druggable pathways. Proteins exist as spatial isoforms with each localized to unique subcellular compartments. These studies, however, lack any spatial information about the AD perturbations. This study performed quantitative MS analysis on biological fractions on three different AD samples to determine the vulnerability of different spatial isoforms to pathogenesis. Method: The following samples were analyzed by quantitative MS: 1)27 human post‐mortem hippocampi from 13 AD and 14 ND (non‐demented) individuals, 2) Human cortical AD organoids with either PSEN1(WT/M146V) or APP(WT/swedish) mutations and isogenic control organoids cultured for 3 months, 3) Cortices from AD (APPswe/PSENdelta9) mice and wild‐type litter mates at 2, 5, and 12 months old. All samples were fractionated into 4 biological fractions. Each fraction was labeled with TMT (tandem mass tags) for quantification by an Orbitrap Tribrid mass spectrometer using SPS‐MS3 acquisition. Mice were fed azidohomoalanine (AHA) diet for 4 days, then sacrificed or returned to a normal diet for 7 days before sacrificed. This AHA pulse‐chase strategy allows for quantitation of protein degradation rates. Result: In the human hippocampi, fraction specific protein identifications revealed an enrichment of unique subcellular compartments. There were 1905 unique proteins observed to significantly different between AD and ND when the fraction MS datasets were combined. Seventy‐eight percent of these changes were specific to one fraction even though 89% of these proteins were quantified in more than one fraction. These protein perturbations were significantly enriched in the biological process of vesicle transport which included endosomal and nucleo‐cytoplasmic trafficking. Reciprocal expression patterns of identical proteins were quantitated in different fractions indicating protein mislocalization. Analysis of AD organoids replicated the findings of vesicle transport dysfunction. In the AD mouse model, global differences in protein degradation rates were observed between AD and WT as early as 2months, but the number of differences were dramatically increased with age. Identical proteins quantitated in different fractions possess distinguishable degradation rates. Conclusion: AD pathogenesis perturbs specific protein isoforms which may stem from the dysfunction of protein trafficking or local degradation pathways.
- 23 December 2025
- Published by Wiley in Alzheimer's & Dementia
- Vol. 21 (S1) , e103003
Open AccessAlzheimer's Disease Pathogenesis Perturbs Specific Spatial Protein Isoforms
Background: Unbiased mass spectrometry (MS) analyses have quantitated hundreds of Alzheimer's Disease (AD) human brain samples to reveal potential druggable pathways. Proteins exist as spatial isoforms with each localized to unique subcellular compartments. These studies, however, lack any spatial information about the AD perturbations. This study performed quantitative MS analysis on biological fractions on three different AD samples to determine the vulnerability of different spatial isoforms to pathogenesis. Method: The following samples were analyzed by quantitative MS: 1)27 human post‐mortem hippocampi from 13 AD and 14 ND (non‐demented) individuals, 2) Human cortical AD organoids with either PSEN1(WT/M146V) or APP(WT/swedish) mutations and isogenic control organoids cultured for 3 months, 3) Cortices from AD (APPswe/PSENdelta9) mice and wild‐type litter mates at 2, 5, and 12 months old. All samples were fractionated into 4 biological fractions. Each fraction was labeled with TMT (tandem mass tags) for quantification by an Orbitrap Tribrid mass spectrometer using SPS‐MS3 acquisition. Mice were fed azidohomoalanine (AHA) diet for 4 days, then sacrificed or returned to a normal diet for 7 days before sacrificed. This AHA pulse‐chase strategy allows for quantitation of protein degradation rates. Result: In the human hippocampi, fraction specific protein identifications revealed an enrichment of unique subcellular compartments. There were 1905 unique proteins observed to significantly different between AD and ND when the fraction MS datasets were combined. Seventy‐eight percent of these changes were specific to one fraction even though 89% of these proteins were quantified in more than one fraction. These protein perturbations were significantly enriched in the biological process of vesicle transport which included endosomal and nucleo‐cytoplasmic trafficking. Reciprocal expression patterns of identical proteins were quantitated in different fractions indicating protein mislocalization. Analysis of AD organoids replicated the findings of vesicle transport dysfunction. In the AD mouse model, global differences in protein degradation rates were observed between AD and WT as early as 2months, but the number of differences were dramatically increased with age. Identical proteins quantitated in different fractions possess distinguishable degradation rates. Conclusion: AD pathogenesis perturbs specific protein isoforms which may stem from the dysfunction of protein trafficking or local degradation pathways.
- 26 June 2025
- Published by American Chemical Society (ACS) in Journal of Proteome Research
- Vol. 24 (8) , 3913-3930
Quantitative Proteomic Analysis Reveals JMJD6 and DNAJB11 as Endogenous Substrates of E3 Ligase RFFL
The ubiquitin-proteasome system contributes to protein quality control, involving E3 ligases that ubiquitinate proteins and leading to their degradation. The dysregulation of protein degradation results in the abnormal accumulation of proteins and is implicated in the pathology of diverse diseases, making targeted protein degradation a promising therapeutic strategy. Here, we focus on RFFL, an endosome-associated RING E3 ligase involved in mitochondrial homeostasis and the clearance of misfolded cystic fibrosis transmembrane conductance regulator proteins. Using label-free quantitative mass spectrometry based proteomics for interactome and differential expression analyses, we systematically investigated and identified putative substrates of RFFL. For more confident identification, we performed these analyses on three cell lines that we generated: an RFFL knockout cell line generated using CRISPR/Cas9, another cell line rescuing RFFL expression when complemented with KO cells with stably expressing RFFL cDNA, and wild-type cells. We validated JMJD6 and DNAJB11 as substrates of endogenous RFFL, providing orthogonal validation and confidence in our screening approach. We demonstrated that RFFL ubiquitinates and degrades JMJD6 and DNAJB11 via the proteasomal pathway using in vivo assays. Interestingly, we also discovered a hitherto unknown role of RFFL in lipid metabolism. Collectively, this study provides the first comprehensive and unbiased analysis of RFFL substrates employing multiple complementary approaches.
- 26 June 2025
- Published by American Chemical Society (ACS) in Journal of Proteome Research
- Vol. 24 (8) , 3913-3930
Quantitative Proteomic Analysis Reveals JMJD6 and DNAJB11 as Endogenous Substrates of E3 Ligase RFFL
The ubiquitin-proteasome system contributes to protein quality control, involving E3 ligases that ubiquitinate proteins and leading to their degradation. The dysregulation of protein degradation results in the abnormal accumulation of proteins and is implicated in the pathology of diverse diseases, making targeted protein degradation a promising therapeutic strategy. Here, we focus on RFFL, an endosome-associated RING E3 ligase involved in mitochondrial homeostasis and the clearance of misfolded cystic fibrosis transmembrane conductance regulator proteins. Using label-free quantitative mass spectrometry based proteomics for interactome and differential expression analyses, we systematically investigated and identified putative substrates of RFFL. For more confident identification, we performed these analyses on three cell lines that we generated: an RFFL knockout cell line generated using CRISPR/Cas9, another cell line rescuing RFFL expression when complemented with KO cells with stably expressing RFFL cDNA, and wild-type cells. We validated JMJD6 and DNAJB11 as substrates of endogenous RFFL, providing orthogonal validation and confidence in our screening approach. We demonstrated that RFFL ubiquitinates and degrades JMJD6 and DNAJB11 via the proteasomal pathway using in vivo assays. Interestingly, we also discovered a hitherto unknown role of RFFL in lipid metabolism. Collectively, this study provides the first comprehensive and unbiased analysis of RFFL substrates employing multiple complementary approaches.
- Open Access
PrP C -induced signaling in human neurons activates phospholipase Cɣ1 and an Arc/Arg3.1 response
Synaptic dysfunction and loss correlate with cognitive decline in neurodegenerative diseases, including Alzheimer’s disease (AD) and prion disease. Neuronal hyperexcitability occurs in the early stages of AD and experimental prion disease, prior to the onset of dementia, yet the underlying drivers are unclear. Here we identify an increase in the immediate early gene, Arc/Arg3.1, in the human prion disease-affected frontal cortex, suggestive of neuronal hyperactivity. To investigate early signaling events initiated by prion aggregates (PrP Sc ) in human neurons, we stimulated PrP C in human iPSC-derived excitatory neurons (iNs) with a known PrP Sc -mimetic antibody (POM1), which recapitulated the Arc/Arg3.1 response within two hours. Proteomics, RNAseq, and a phosphokinase array in iNs revealed alterations in the EGF receptor and increased phosphorylated phospholipase C (PLC)-γ1 (Y783), which was also observed in the cerebral cortex of prion-infected mice. Thus, PrP C ligands can induce a PLC-γ1 intracellular signaling cascade together with an Arc response, suggestive of a neuronal activity response.
Open AccessPrP C -induced signaling in human neurons activates phospholipase Cɣ1 and an Arc/Arg3.1 response
Synaptic dysfunction and loss correlate with cognitive decline in neurodegenerative diseases, including Alzheimer’s disease (AD) and prion disease. Neuronal hyperexcitability occurs in the early stages of AD and experimental prion disease, prior to the onset of dementia, yet the underlying drivers are unclear. Here we identify an increase in the immediate early gene, Arc/Arg3.1, in the human prion disease-affected frontal cortex, suggestive of neuronal hyperactivity. To investigate early signaling events initiated by prion aggregates (PrP Sc ) in human neurons, we stimulated PrP C in human iPSC-derived excitatory neurons (iNs) with a known PrP Sc -mimetic antibody (POM1), which recapitulated the Arc/Arg3.1 response within two hours. Proteomics, RNAseq, and a phosphokinase array in iNs revealed alterations in the EGF receptor and increased phosphorylated phospholipase C (PLC)-γ1 (Y783), which was also observed in the cerebral cortex of prion-infected mice. Thus, PrP C ligands can induce a PLC-γ1 intracellular signaling cascade together with an Arc response, suggestive of a neuronal activity response.
- Open Access
- 4 April 2025
- Published by American Society for Clinical Investigation in Journal of Clinical Investigation
- Vol. 135 (10)
Mutant prion protein enhances NMDA receptor activity, activates PKC, and triggers rapid excitotoxicity in mice
Neuronal hyperexcitability precedes synapse loss in certain neurodegenerative diseases, yet the synaptic membrane interactions and downstream signaling events remain unclear. The disordered amino terminus of the prion protein (PrP C ) has been implicated in aberrant signaling in prion and Alzheimer’s disease. To disrupt neuronal interactions and signaling linked to the amino terminus, we CRISPR-engineered a knockin mouse expressing mutant PrP C (G92N), generating an N -linked glycosylation site between 2 functional motifs. Mice developed seizures and necrosis of hippocampal pyramidal neurons, similar to prion-infected mice and consistent with excitotoxicity. Phosphoproteomics analysis revealed phosphorylated glutamate receptors and calcium-sensitive kinases, including protein kinase C (PKC). Additionally, 92N-PrP C -expressing neurons showed persistent calcium influx as well as dendritic beading, which was rescued by an N -methyl-d-aspartate receptor (NMDAR) antagonist. Finally, survival of Prnp 92N mice was prolonged by blocking active NMDAR channels. We propose that dysregulated PrP C -NMDAR–induced signaling can trigger an excitatory-inhibitory imbalance, spongiform degeneration, and neurotoxicity and that calcium dysregulation is central to PrP C -linked neurodegeneration.
- 4 April 2025
- Published by American Society for Clinical Investigation in Journal of Clinical Investigation
- Vol. 135 (10)
Open AccessMutant prion protein enhances NMDA receptor activity, activates PKC, and triggers rapid excitotoxicity in mice
Neuronal hyperexcitability precedes synapse loss in certain neurodegenerative diseases, yet the synaptic membrane interactions and downstream signaling events remain unclear. The disordered amino terminus of the prion protein (PrP C ) has been implicated in aberrant signaling in prion and Alzheimer’s disease. To disrupt neuronal interactions and signaling linked to the amino terminus, we CRISPR-engineered a knockin mouse expressing mutant PrP C (G92N), generating an N -linked glycosylation site between 2 functional motifs. Mice developed seizures and necrosis of hippocampal pyramidal neurons, similar to prion-infected mice and consistent with excitotoxicity. Phosphoproteomics analysis revealed phosphorylated glutamate receptors and calcium-sensitive kinases, including protein kinase C (PKC). Additionally, 92N-PrP C -expressing neurons showed persistent calcium influx as well as dendritic beading, which was rescued by an N -methyl-d-aspartate receptor (NMDAR) antagonist. Finally, survival of Prnp 92N mice was prolonged by blocking active NMDAR channels. We propose that dysregulated PrP C -NMDAR–induced signaling can trigger an excitatory-inhibitory imbalance, spongiform degeneration, and neurotoxicity and that calcium dysregulation is central to PrP C -linked neurodegeneration.
- 10 February 2025
- Published by American Chemical Society (ACS) in ACS Chemical Biology
- Vol. 20 (2) , 442-454
Insights into Free Drug Release from Efficacious N-Acyl O-Aminophenol Duocarmycin Prodrugs
Acyclic and cyclic N-acyl O-aminophenol prodrugs of duocarmycin analogues were reported as members of a unique class of reductively cleaved prodrugs that map seamlessly onto the duocarmycin family of natural products. Although these prodrugs were explored with the expectations that they may be cleaved selectively within hypoxic tumor environments that have intrinsically higher concentrations of reducing nucleophiles, the remarkable stability of some such prodrugs suggests another mechanism of free drug release is operative. The prototype of such chemically unreactive N-acyl O-aminophenol prodrugs is 1, which proved remarkably efficacious in vivo in vertebrate tumor models; was found to lack the toxicity that is characteristic of traditional chemotherapeutic drugs as well as the free drugs in the class (e.g., myelosuppression); and displayed a preferential site (intracellular), a slow and sustained rate, and a potentially unique mechanism of free drug release. Herein, we detail studies that provide insights into this stereoselective mechanism of free drug release. Combined, the results of the studies are consistent with an exclusive protein-mediated (enantio)selective activation and free drug release from prodrug 1 by N-O bond cleavage preferentially in cancer cell lines versus cultured normal human cell lines effected by a cytosolic cysteine-based enzyme and suggest that the activating protein is one that is selectively expressed, upregulated, or preferentially activated in cancer cell lines, potentially constituting a new oncology targeted precision therapy.
- 10 February 2025
- Published by American Chemical Society (ACS) in ACS Chemical Biology
- Vol. 20 (2) , 442-454
Insights into Free Drug Release from Efficacious N-Acyl O-Aminophenol Duocarmycin Prodrugs
Acyclic and cyclic N-acyl O-aminophenol prodrugs of duocarmycin analogues were reported as members of a unique class of reductively cleaved prodrugs that map seamlessly onto the duocarmycin family of natural products. Although these prodrugs were explored with the expectations that they may be cleaved selectively within hypoxic tumor environments that have intrinsically higher concentrations of reducing nucleophiles, the remarkable stability of some such prodrugs suggests another mechanism of free drug release is operative. The prototype of such chemically unreactive N-acyl O-aminophenol prodrugs is 1, which proved remarkably efficacious in vivo in vertebrate tumor models; was found to lack the toxicity that is characteristic of traditional chemotherapeutic drugs as well as the free drugs in the class (e.g., myelosuppression); and displayed a preferential site (intracellular), a slow and sustained rate, and a potentially unique mechanism of free drug release. Herein, we detail studies that provide insights into this stereoselective mechanism of free drug release. Combined, the results of the studies are consistent with an exclusive protein-mediated (enantio)selective activation and free drug release from prodrug 1 by N-O bond cleavage preferentially in cancer cell lines versus cultured normal human cell lines effected by a cytosolic cysteine-based enzyme and suggest that the activating protein is one that is selectively expressed, upregulated, or preferentially activated in cancer cell lines, potentially constituting a new oncology targeted precision therapy.
- 23 November 2024
- Published by American Chemical Society (ACS) in Journal of Proteome Research
- Vol. 23 (12) , 5487-5497
Acid Cleavable Biotin-Alkyne Improves Sensitivity for Direct Detection of Biotin Labeled Peptides in Biorthogonal Noncanonical Amino Acid Tagging Analysis
Biorthogonal noncanonical amino acid tagging is a labeling strategy that covalently adds a biotin-alkyne (BA) to methionine analogs via a click reaction. When methionine analogs are incorporated into a proteome, enrichment of the BA-labeled proteins allows the detection of newly synthesized proteins (NSP) by mass spectrometry. We previously reported that our direct detection of biotin-containing tags strategy increased protein identifications by enriching for BA-peptides instead of BA-proteins. We compared the performance of cleavable BA (DADPS) and uncleavable BA in the identification and TMT quantification of the NSP. DADPS identified and quantified more than double the number of peptides than uncleavable BA. Interrogation of the data revealed that multiple factors are responsible for the superior performance of DADPS.
- 23 November 2024
- Published by American Chemical Society (ACS) in Journal of Proteome Research
- Vol. 23 (12) , 5487-5497
Acid Cleavable Biotin-Alkyne Improves Sensitivity for Direct Detection of Biotin Labeled Peptides in Biorthogonal Noncanonical Amino Acid Tagging Analysis
Biorthogonal noncanonical amino acid tagging is a labeling strategy that covalently adds a biotin-alkyne (BA) to methionine analogs via a click reaction. When methionine analogs are incorporated into a proteome, enrichment of the BA-labeled proteins allows the detection of newly synthesized proteins (NSP) by mass spectrometry. We previously reported that our direct detection of biotin-containing tags strategy increased protein identifications by enriching for BA-peptides instead of BA-proteins. We compared the performance of cleavable BA (DADPS) and uncleavable BA in the identification and TMT quantification of the NSP. DADPS identified and quantified more than double the number of peptides than uncleavable BA. Interrogation of the data revealed that multiple factors are responsible for the superior performance of DADPS.
- Open Access
- 29 October 2024
- Published by Springer Nature in Nature Communications
- Vol. 15 (1) , 1-17
Using in vivo intact structure for system-wide quantitative analysis of changes in proteins
Mass spectrometry-based methods can provide a global expression profile and structural readout of proteins in complex systems. Preserving the in vivo conformation of proteins in their innate state is challenging during proteomic experiments. Here, we introduce a whole animal in vivo protein footprinting method using perfusion of reagents to add dimethyl labels to exposed lysine residues on intact proteins which provides information about protein conformation. When this approach is used to measure dynamic structural changes during Alzheimer’s disease (AD) progression in a mouse model, we detect 433 proteins that undergo structural changes attributed to AD, independent of aging, across 7 tissues. We identify structural changes of co-expressed proteins and link the communities of these proteins to their biological functions. Our findings show that structural alterations of proteins precede changes in expression, thereby demonstrating the value of in vivo protein conformation measurement. Our method represents a strategy for untangling mechanisms of proteostasis dysfunction caused by protein misfolding. In vivo whole-animal footprinting should have broad applicability for discovering conformational changes in systemic diseases and for the design of therapeutic interventions.
- 29 October 2024
- Published by Springer Nature in Nature Communications
- Vol. 15 (1) , 1-17
Open AccessUsing in vivo intact structure for system-wide quantitative analysis of changes in proteins
Mass spectrometry-based methods can provide a global expression profile and structural readout of proteins in complex systems. Preserving the in vivo conformation of proteins in their innate state is challenging during proteomic experiments. Here, we introduce a whole animal in vivo protein footprinting method using perfusion of reagents to add dimethyl labels to exposed lysine residues on intact proteins which provides information about protein conformation. When this approach is used to measure dynamic structural changes during Alzheimer’s disease (AD) progression in a mouse model, we detect 433 proteins that undergo structural changes attributed to AD, independent of aging, across 7 tissues. We identify structural changes of co-expressed proteins and link the communities of these proteins to their biological functions. Our findings show that structural alterations of proteins precede changes in expression, thereby demonstrating the value of in vivo protein conformation measurement. Our method represents a strategy for untangling mechanisms of proteostasis dysfunction caused by protein misfolding. In vivo whole-animal footprinting should have broad applicability for discovering conformational changes in systemic diseases and for the design of therapeutic interventions.